Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2012
08/09/2012US20120201782 Peptide, adjuvants, vaccines, and methods of use
08/09/2012US20120201781 Treatment of osteoarthritis and pain
08/09/2012US20120201780 T. cruzi-derived neurotrophic agents and methods of use therefor
08/09/2012US20120201766 Topical Compositions Comprising An Alkoxylated Diphenylacrylate Compound And An Organic Nonionic Emulsifier
08/09/2012US20120201757 Mutant low-density lipoprotein receptor related protein with increased binding to alzheimer amyloid-beta peptide
08/09/2012US20120201753 Methods and compositions related to targeting wounds, regenerating tissue, and tumors
08/09/2012US20120201750 Serum biomarkers for melanoma metastasis
08/09/2012US20120201748 Coacervate having an ionic polymer mixed with the adhesive protein of a mussel or of a species of the variome thereof
08/09/2012US20120201747 System and Method for Diagnosis and Treatment
08/09/2012US20120199516 Method for treating multiple sclerosis
08/09/2012CA2826251A1 Psa capture agents, compositions, methods and preparation thereof
08/09/2012CA2826200A1 Caspase-2 inhibitors
08/09/2012CA2826192A1 Methods and compositions for treating bacterial infections with iron chelators
08/09/2012CA2826114A1 Cardiotrophin related molecules for enhanced therapeutics
08/09/2012CA2825884A1 Ubiquitin interacting motif peptides as cancer therapeutics
08/09/2012CA2825641A1 Use of icam-1 for prevention or treatment of neurological diseases
08/09/2012CA2825162A1 Prevention of hypoglycaemia in diabetes mellitus type 2 patients
08/09/2012CA2823870A1 Inhibitors of the interaction of the sigma-1 receptor with herg for use in the treatment of cancer
08/09/2012CA2793515A1 Methods for treating diabetic foot ulcers
08/08/2012EP2484763A2 Neukinase, a downstream protein of neuregulin
08/08/2012EP2484692A1 Apolipoprotein a-1 mimic peptides, and therapeutic agent for treating hyperlipidemia and diseases related to hyperlipidemia comprising same
08/08/2012EP2484691A1 TNF superfamily collectin fusion proteins
08/08/2012EP2484688A1 Peptide epoxyketones for proteasome inhibition
08/08/2012EP2484381A1 Composition for a treatment of demyelinating diseases and paralysis by administration of remyelinating agents
08/08/2012EP2484373A1 High frequency application of botulinum toxin therapy
08/08/2012EP2484372A1 Activin-ActRIIa Antagonists and Uses for Promoting Bone Growth in Cancer Patients
08/08/2012EP2484371A1 Use of Hsp70 as a regulator of enzymatic activity
08/08/2012EP2484370A1 Composition having lipolysis-promoting effect
08/08/2012EP2484365A1 Compositions and method for treatment of neovascular diseases
08/08/2012EP2484364A1 Compositionas and methods for treatment of neovascular diseases
08/08/2012EP2484360A1 Phenylboronic acid compounds as antiviral agents
08/08/2012EP2483303A1 T-cell receptor capable of recognising an antigen from cytomegalovirus
08/08/2012EP2483302A2 Parstatin peptides
08/08/2012EP2483300A1 Synthetic myostatin peptide antagonists
08/08/2012EP2483290A1 Cyclic peptide inhibitors of hepatitis c virus replication
08/08/2012EP2483273A1 Novel macrocyclic inhibitors of hepatitis c virus replication
08/08/2012EP2482903A1 Improved method for treatment of patients with cystic fibrosis
08/08/2012EP2482842A1 Cancer therapy
08/08/2012EP2482841A1 Compositions and methods for enhancing coagulation factor viii function
08/08/2012EP2482840A2 Val (8) glp-1 composition and method for treating functional dyspepsia and/or irritable bowel syndrome
08/08/2012EP2482839A1 Means and methods for treating ischemic conditions
08/08/2012EP2482838A1 Use of botulinum neurotoxin to treat substance addictions
08/08/2012EP2482837A2 Use of protein kinase c delta (pkcd) inhibitors to treat diabetes, obesity, and hepatic steatosis
08/08/2012EP2482836A1 Antibacterial polypeptides and use thereof
08/08/2012EP2482835A1 Therapy and prevention of problem drinking
08/08/2012EP2482834A1 Peptides for inducing heterosubtypic influenza t cell responses
08/08/2012EP2482833A1 Leptin agonist and methods of use
08/08/2012EP2268657B1 Histidine related compounds for identifying and blocking amyloid beta ion channels
08/08/2012EP2190535B1 Somatostatin-14 for use in the prophylaxis and/or treatment of HBV
08/08/2012EP2190447B1 His-Pro-Gly-Ser-Arg-lle-Val-Leu-Ser-Leu-Asp-Val-Pro-lle-Gly-Leu-Leu-Gln-Ile-Leu-Leu-Glu-Gln-Ala-Arg-Ala-Arg-Ala-Ala-Arg-Glu-Gln-Ala-Thr-Thr-Asn-Ala-Arg-ile-Leu-Ala-Arg-Val-NH2 for use in anti-angiogenic therapy
08/08/2012EP2187901B1 Neuropeptide El optionally combined with ACTH (7-38) for use in anti-angiogenic therapy
08/08/2012EP2155231B1 Imaging and therapy of virus-associated tumors
08/08/2012EP2124997B1 Use of il-1 antagonists to treat gout and pseudogout
08/08/2012EP2054050B1 Treatment of cartilage disorders with fgf-18
08/08/2012EP2005171B1 Inflammation-inhibitory serum factors and uses thereof
08/08/2012EP1959982B1 Methods and compositions for preventing and/or treating pancreatitis
08/08/2012EP1933861B1 Method for treating or preventing multi-organ failure
08/08/2012EP1924275B1 Thio-containing inhibitors of aminopeptidase p, compositions thereof and method of use
08/08/2012EP1913954B1 Use of the eda domain of fibronectin
08/08/2012EP1888085B1 Methods for providing palliative care with product r
08/08/2012EP1871880B1 Chimeric proteins comprising yersinia yop, their preparation and pharmaceutical compositions containing them
08/08/2012EP1768647B1 Compositions comprising a mucoadhesive protein and an active principle for mucosal delivery of said agent
08/08/2012EP1631670B1 Conserved hbv and hcv sequences useful for gene silencing
08/08/2012EP1569685B1 Complement receptor 2 targeted complement modulators
08/08/2012EP1383536B1 Use of herpesviruses to inhibit ccr5-tropic hiv-1 infection and replication
08/08/2012EP1127148B1 Variants of humanized anti-carcinoma monoclonal antibody cc49
08/08/2012EP0951551B2 Ligand for receptor activator of nf-kappa b, ligand is member of tnf superfamily
08/08/2012EP0837938B1 Use of mp52 or mp121 for treating and preventing diseases of the nervous system
08/08/2012CN102630164A Pancreatic enzyme compositions and methods for treating pancreatitis and pancreatic insufficiency
08/08/2012CN102628073A Glycosylated lactalbumin polypeptide with antioxidant activity as well as preparation method and application of glycosylated lactalbumin polypeptide
08/08/2012CN102628048A Preparation and application of conotoxin Lt7b of Conus littertus Linnaeus of South China sea
08/08/2012CN102627689A Hydrate of cyclopeptide compound as well as preparation method and application thereof
08/08/2012CN102627688A High purity cyclic peptide compound and preparation method and application thereof
08/08/2012CN102627686A Polypeptide with effect of inhibiting activity of fibroblast growth factor receptor 3 and application thereof
08/08/2012CN102627685A Nitric oxide-donating glutathione compound, preparation method and medical purpose thereof
08/08/2012CN102205115B Application of ulinastatin serving as rescue auxiliary medicament for toxic shock caused by acute abdomen
08/08/2012CN102188692B Bone peptide composition, preparation thereof, preparation method thereof and application
08/08/2012CN101967182B Antimicrobial compound and preparation method and application thereof
08/08/2012CN101935346B Mutated human-source fibroblast growth factor and application in treating endocrine diseases
08/08/2012CN101897952B Application of trefoil factor 3 to preparing medicament for preventing and/or treating depressive disorder
08/08/2012CN101842118B Use of hydrophobin polypeptides as penetration enhancers
08/08/2012CN101792489B Preparation and application of human galectin-9 deletant for enhancement of immune response
08/08/2012CN101781366B Novel antibacterial peptide and preparation method and application thereof
08/08/2012CN101781359B Novel antibacterial peptide and preparation method and application thereof
08/08/2012CN101781358B Novel antibacterial peptide and preparation method and application thereof
08/08/2012CN101516902B Polypeptides and polynucleotides encoding same and use thereof in the treatment of medical conditions associated with ischemia
08/08/2012CN101495131B Novel antibacterial compounds
08/08/2012CN101468200B Beauty treatment health-care capsule produced from deep sea fish collagen and preparation thereof
08/08/2012CN101307310B Expression system with recombination protein for increasing yield and immunogenicity
08/08/2012CN101195822B High-endophilicity targeting amalgamation protein
08/08/2012CN101090731B Use of bombesin/gastrin-releasing peptide antagonists for the treatment of inflammatory conditions, acute lung injury and bipolar disorder
08/08/2012CN101056652B Methods for treating local tracheal, bronchial or alveolar bleeding or hemoptysis
08/07/2012US8236944 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
08/07/2012US8236927 Stabilizer molecule-depleted albumin solution
08/07/2012US8236924 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
08/07/2012US8236836 Composition comprising at least one oxazoline for inhibiting langerhans cell migration, and uses thereof
08/07/2012US8236807 Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors
08/07/2012US8236800 antimicrobial agents and antidote for hemorrhagic complications associated with heparin therapy; peptide having optimal sites of polar and nonpolar substituents that confer amphiphilic properties; leucine and aminobenzoic acid derivative; isophthalic acid and diaminobenzene, 3-tert-butyl-6-alkylthio cmpd
08/07/2012US8236775 Compositions and methods for siRNA inhibition of HIF-1 α
08/07/2012US8236774 Human telomerase catalytic subunit
1 ... 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 ... 3163